2nd Jul 2014 15:11
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.
On 30 June 2014, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £15.67 per Ordinary Share, and notional ADSs at a price of $53.64 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2014 to 30 June 2014:
Non Executive Director | Ordinary Shares | American Depositary Shares (ADSs) |
Sir Christopher Gent | 3,988.513 | |
Professor Sir Roy Anderson | 578.334 | |
Dr Stephanie Burns |
| 433.930 |
Stacey Cartwright | 458.679 | |
Lynn Elsenhans | 577.315 | |
Judy Lewent | 367.897 | |
Sir Deryck Maughan | 1,094.258 | |
Dr Daniel Podolsky | 820.694 | |
Tom de Swaan | 538.449 | |
Jing Ulrich | 273.565 | |
Hans Wijers | 458.679 | |
The Company and the Non-Executive Directors were informed of these allocations on 1 July 2014.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
2 July 2014
Related Shares:
Glaxosmithkline